LBEPB15	Neural tube defects and major external structural abnormalities by antiretroviral treatment regimen in Botswana: 2014-2022	E-poster	Antiretroviral therapies and clinical issues in infants, children and adolescents
LBEPB16	HIV drug resistance profile in clients experiencing treatment failure after the transition to a dolutegravir-based, first-line antiretroviral treatment regimen in Mozambique	E-poster	ART resistance
LBEPB17	Analytical treatment interruption among African women and Peruvian men & transgender individuals with early ART initiation +/- VRC01 circulating at HIV acquisition: early observations of viral rebound & control	E-poster	Other strategies and therapies
LBEPB18	Anti-PD-L1 antibody ASC22 in combination with chidamide potentiates HIV latency reversal and immune function from ART-suppressed individuals: a single center, single-arm, phase 2 study	E-poster	Other strategies and therapies
LBEPB19	Factors associated with COVID-19 vaccination uptake amongst PLHIV in southern Nigeria	E-poster	SARS-CoV-2, COVID-19 and HIV
LBEPB20	T-cell responses induced by HTI vaccines and vesatolimod correlate with improved control of HIV rebound	E-poster	Other strategies and therapies
LBEPC21	HIV transmission clusters in Zambia are smaller than in Europe: evidence from the HPTN-071 (PopART) study, BEEHIVE study, and individual-based models	E-poster	Surveillance: Measuring the HIV epidemic
LBEPC22	Preliminary results of the bio behavioral survey among prisoners in Mozambique	E-poster	Surveillance: Measuring the HIV epidemic
LBEPC23	Relative risk of death during pre-Delta, Delta and Omicron variants waves among children and adults hospitalized with COVID-19 in Africa	E-poster	Epidemiology of COVID-19
LBEPC24	Growth and neurodevelopmental outcomes of 18-month-old children with exposure to maternal HIV and placental insufficiency in a peri-urban area of South Africa	E-poster	Population-specific interventions for HIV prevention